
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES53
A retrospective chart review67 found a significantly reduced frequency of GI AE in a cohort of
patients when they were switched from MIR to MXR. A cohort of patients taking metformin
for the first time also experienced less GI AEs if they were commenced on MXR rather than the
immediate-release formulation. Level 2+

[@Blonde_2004]

